Tag: PERSEVERE
Artivion announces US FDA approval of AMDS hybrid prosthesis
The US Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for Artivion's AMDS hybrid prosthesis (AMDS), a press release reveals.
The...
Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial
Artivion has announced presentation of interim results from the Ascyrus medical dissection stent (AMDS) PERSEVERE clinical trial in a late-breaking science session at the...
